Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2019 Earnings

6NovExpected

Q4 2018

Q1 2019

Q2 2019

Q3 2019

-16.5

-11.12

-5.75

-0.37

Details

Expected EPS

-0.54

Actual EPS

-16.5

Surprise EPS

-15.96

Surprise Percent

+2,955.56%

Description

Spyre Therapeutics (SYRE) has reported earnings of -16.5 per share for Q3 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.